Login | SITEMAP | FAQS

Research & Scientists | Neurosciences | People | ANAXSMAGALHAES

 

Name: Ana Xavier Magalhães

Office: I1.02

School Phone: +351 253 604 837

Email: anaxsmagalhaes@med.uminho.pt

 

 

 

Keywords: Neuro-Oncology Glioblastoma non-coding RNAs

About

Ana Xavier Magalhães graduated in Biochemistry in 2011 and completed her master degree in Molecular Genetics in 2012 by the University of Minho (Portugal). Ana is currently doing her PhD in Health Sciences at Life and Health Sciences Research Institute (ICVS), University of Minho (Portugal). Her work is focused on the study of molecular markers in the prognosis and therapeutic responses of human brain tumors.


Honors and Prizes
2012  Portuguese Science Foundation (FCT) PhD scholarship


Publications
-A. Xavier Magalhães and B. M. Costa. Molecular Determinants of Glioma Risk and Patients Prognosis. LAP LAMBERT Academic Publishing GmbH & Co. KG, 2012. ISBN: 978-3-8573-3502-3.
-A. Xavier Magalhães, J. Vieira de Castro, and B. M. Costa. General Epidemiology and Classification of Primary Brain and Central Nervous System Tumors in Molecular Determinants of Glioma Risk and Patients Prognosis. LAP LAMBERT Academic Publishing GmbH & Co. KG, 2012. ISBN: 978-3-8573-3502-3. pp: 3-15
-A. Xavier Magalhães and B. M. Costa. Etiology and Risk Factors for Glioma in Molecular Determinants of Glioma Risk and Patients Prognosis. LAP LAMBERT Academic Publishing GmbH & Co. KG, 2012. ISBN: 978-3-8573-3502-3. pp: 17-30
-C. Gonçalves, A. Xavier Magalhães, and B. M. Costa. Molecular Pathology of Glioma in Molecular Determinants of Glioma Risk and Patients Prognosis. LAP LAMBERT Academic Publishing GmbH & Co. KG, 2012. ISBN: 978-3-8573-3502-3. pp: 31-55
-T. Lourenço, A. Xavier Magalhães, and B. M. Costa. Treatment and Prognostic Factors of Malignant Glioma in Molecular Determinants of Glioma Risk and Patients Prognosis. LAP LAMBERT Academic Publishing GmbH & Co. KG, 2012. ISBN: 978-3-8573-3502-3. pp: 57-68
-C. S. Gonçalves, T. Lourenço, A. Xavier-Magalhães, M. Pojo, B. M. Costa. Mechanisms of Aggressiveness in GBM: Prognostic and Potential Therapeutic Insights in Brain Tumors / Book 2. InTech Publishers, 2012. ISBN: 980-953-307-523-0.


Projects

Translating Mechanisms of Aggressiveness in Brain Tumors into Prognostic and Therapeutic Value: Insights from the Oncogenic HOXA9 Homeoprotein  

Selected Publications

Pojo M, Gonçalves CS, Xavier-Magalhães A, Oliveira AI, Gonçalves T, Correia S, Rodrigues AJ, Costa S, Pinto L, Pinto AA, Lopes JM, Reis RM, Rocha M, Sousa N, Costa BM. A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide. Oncotarget, 6(10):7657-7674 (2015).

Bell RJA, Rube HT, Xavier-Magalhães A, Costa BM, Mancini A, Song JS, Costello JF. Understanding TERT Promoter Mutations: a Common Path to Immortality. Molecular Cancer Research, 2016; 14(4): 315-323.

Bell RJA, Rube HT, Xavier-Magalhães A, Costa BM, Mancini A, Song JS, Costello JF. Understanding TERT Promoter Mutations: a Common Path to Immortality. Mol Cancer Res, 14(4):315-323 (2016)

Pojo M, Cerqueira SR, Mota T, Xavier-Magalhães A, Oliveira JM, Ribeiro-Samy S, Mano JF, Reis RL, Sousa N, Costa BM, Salgado AJ. In vitro evaluation of the cytotoxicity and cellular uptake of CMCht/PAMAM dendrimer nanoparticles by glioblastoma cell models. J Nanoparticle Res, 15:1621-1626 (2013).

Gonçalves CS, Xavier-Magalhães A, Pojo M, Oliveira AI, Correia S, Reis RM, Sousa N, Rocha M, Costa BM. Transcriptional profiling of HOXA9-regulated genes in human glioblastoma cell models. Genomics Data, 5:54–58 (2015).

Copyright © 2012-2016 ICVS. All rights reserved.